MuTian, Xraphconn, 200mg *20capsules

MuTian, Xraphconn, 200mg *20capsules

Drug Labeling and Warnings

Drug Details

k">

MUTIAN XRAPHCONN- drug for treatment of fip capsule 
Nantong MUTIAN Biotechnology Co., Ltd

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

MuTian, Xraphconn, 200mg *20capsules

For cats use only, Not for human use.
Keep out of reach of children and animals.
It is forbidden to use for cats who are allergic to the active ingredients or any excipients of this products.

For the treatment of Feline Infectious Peritonitis (FIP).
Oral use.
This drug is recommended for taking on an empty stomach.
Consult your veterinarian for help in the diagnosis, treatment and control of FIP.

The daily dose for MUTIAN is 100mg/kg of body weight.

Inotodiol

Nicotinamide Mononucleotide
Crocin
S-Adenosylmethionine
Silymarin
Microcrystalline cellulose

In clinical studies 7 of 240 cats (about 3% of the treated cats) had vomiting associated with the use of the product.

Keep out of reach of children and animals.

Store at the room temperature.

Outer Package

Outer Package

MUTIAN XRAPHCONN 
drug for treatment of fip capsule
Product Information
Product TypeOTC ANIMAL DRUGItem Code (Source)NDC: 73452-150
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
INONOTUS OBLIQUUS FRUITING BODY (UNII: MRO1FS760M) (INONOTUS OBLIQUUS FRUITING BODY - UNII:MRO1FS760M) INONOTUS OBLIQUUS FRUITING BODY10 mg  in 200 mg
Inactive Ingredients
Ingredient NameStrength
NICOTINAMIDE RIBOTIDE (UNII: 2KG6QX4W0V) 30 mg  in 200 mg
CROCIN (UNII: 877GWI46C2) 20 mg  in 200 mg
S-ADENOSYLMETHIONINE SYNTHASE ISOFORM TYPE-2 (UNII: 1LM9SS1UEA) 15 mg  in 200 mg
MILK THISTLE (UNII: U946SH95EE) 25 mg  in 200 mg
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) 100 mg  in 200 mg
Product Characteristics
ColorwhiteScore2 pieces
ShapecapsuleSize8mm
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 73452-150-304000 in 1 PACKAGE
1NDC: 73452-150-02200 mg in 1 CAPSULE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other12/02/201912/03/2019
Labeler - Nantong MUTIAN Biotechnology Co., Ltd (554512204)
Registrant - Nantong MUTIAN Biotechnology Co., Ltd (554512204)
Establishment
NameAddressID/FEIBusiness Operations
Nantong MUTIAN Biotechnology Co., Ltd554512204label, manufacture, api manufacture

Revised: 12/2019
 
Nantong MUTIAN Biotechnology Co., Ltd


© 2019 FDA.report
This site is not affiliated with or endorsed by the FDA.